The FDA advised healthcare professionals to discuss Tavneos and alternative treatment options with patients while a final decision on the drug’s marketing status is pending
Source:
www.thehindu.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.






